OraSure Technologies. (NSDQ: OSUR) added Feb 25, 2011
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.
Recent News: OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
Jeffrey Frelick .....Canaccord/Genuity….May 05, 2011
Maintained BUY
Target $10.00US
OSUR Price day before:$8.29Finish day posting$8.30Current $8.30
------Feb 24, 2011--------
Maintained BUY
Target raised to $10.00 from $8.00US
OSUR Price day before:$6.69Finish day posting$6.59Current $8.30
----Nov 16, 2010------
New BUY
Target $8.00US (Target Hit Apr 01, 2011)
OSUR Price day before:$4.53Finish day posting$4.49Current $8.30
******************
Derek Leckow.....Barrington Research….Nov 30, 2010
New OUTPERFORM
Target $8.00US (Target Hit Apr 01, 2011)
OSUR Price day before:$5.22Finish day posting$5.25Current $8.30
******************
 |